LEADER 05999oam 22007695 450 001 9910789486703321 005 20200520144314.0 010 $a1-283-44659-6 010 $a9786613446596 010 $a0-8213-8808-8 024 7 $a10.1596/978-0-8213-8807-5 035 $a(CKB)3460000000023785 035 $a(EBL)841926 035 $a(OCoLC)773566710 035 $a(SSID)ssj0000590417 035 $a(PQKBManifestationID)12240563 035 $a(PQKBTitleCode)TC0000590417 035 $a(PQKBWorkID)10666129 035 $a(PQKB)10534407 035 $a(MiAaPQ)EBC841926 035 $a(Au-PeEL)EBL841926 035 $a(CaPaEBR)ebr10527223 035 $a(CaONFJC)MIL344659 035 $a(The World Bank)2011039281 035 $a(US-djbf)16969974 035 $a(EXLCZ)993460000000023785 100 $a20110919d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe fiscal dimensions of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda /$fby Elizabeth Lule and Markus Haacker 210 1$aWashington, D.C. :$cWorld Bank,$d2011. 215 $apages cm 300 $aDescription based upon print version of record. 311 $a0-8213-8807-X 320 $aIncludes bibliographical references and index. 327 $aContents; Foreword; Acknowledgments; Abbreviations; Overview; Methodology; Country Summaries; Conclusions; Notes; References; 1 Introduction; Background; Methodology; Notes; References; 2 Botswana; I. Introduction; II. The Impact of HIV/AIDS in Botswana; III. HIV/AIDS and Public Finance; IV. Modeling the Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; 3 South Africa; I. Introduction; II. The Impact of HIV/AIDS in South Africa; III. Stocktaking: HIV/AIDS and Public Finance; IV. Projecting the Fiscal Costs of HIV/AIDS; V. HIV/AIDS as a Fiscal Liability 327 $aVI. ConclusionsVII. Annex; Notes; References; 4 Swaziland; I. Introduction; II. The Impact of HIV/AIDS in Swaziland; III. Stocktaking-HIV/AIDS and Public Finance; IV. The Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; 5 Uganda; I. Introduction; II. The Impact of HIV/AIDS in Uganda; III. HIV/AIDS and Public Finance; IV. The Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; Index; Figures; 0.1 Botswana: Fiscal Costs of HIV/AIDS (2010-30); 0.2 External Financing of HIV/AIDS Programs across Countries 327 $a0.3 Botswana: Costs of One Additional Infection0.4 Botswana: Fiscal Costs of HIV/AIDS, 2010-30; 0.5 South Africa: Evolution of the HIV Epidemic; 0.6 South Africa: Fiscal Costs of HIV/AIDS, "Narrow NSP" Scenario, 2007-31; 0.7 South Africa: Fiscal Costs of HIV/AIDS, "Expanded NSP" Scenario, 2007-31; 0.8 South Africa: Costs of Additional Infection Occurring in 2010, "Narrow NSP" Scenario; 0.9 South Africa: Costs of Additional Infection Occuring in 2010, "Expanded NSP" Scenario; 0.10 South Africa: Fiscal Costs of HIV/AIDS, "Commitment" Basis, "Narrow NSP" Scenario, 2010-31 327 $a0.11 South Africa: Fiscal Costs of HIV/AIDS, "Commitment" Basis, "Expanded NSP" Scenario, 2010-310.12 Swaziland: The Fiscal Costs of HIV/AIDS, 2010-30; 0.13 Swaziland: External HIV/AIDS Support; 0.14 Swaziland: Costs of Additional Infection Occurring in 2010; 0.15 Swaziland: Fiscal Costs of HIV/AIDS; 0.16 Uganda: Mortality by Sex and Age; 0.17 Uganda: Projected Costs of HIV/AIDS Program, 2008-25; 0.18 Uganda: Domestically and Externally Financed HIV/AIDS Spending; 0.19 Uganda: Actual Spending and Costs Incurred by New HIV Infections, 2010-30 327 $a0.20 Uganda: Change in Value of Spending Commitments, 2010-301.1 Southern African Development Community: GDP Growth, 2005-12; 1.2 Macroeconomic Trends, Advanced Economies, 2005-12; 1.3 Demographic and Epidemiological Module; 2.1 Evolution of the HIV Epidemic; 2.2 HIV Prevalence by Age Group, 2004 and 2008; 2.3 Access to Antiretroviral Therapy, 2004-09; 2.4 HIV/AIDS, Mortality, and Morbidity; 2.5 Survival Rates from Age 0 by Sex, 2005-10; 2.6 Life Expectancy and GDP per Capita, 2008; 2.7 Human Development Index and Underlying Factors, Seven Countries; 2.8 Fiscal Outlook, 2008-30 327 $a2.9 Health Expenditures by Source of Financing, 1995-2008 330 $aHIV/AIDS continues to take a tremendous toll on the populations of many countries, especially in sub-Saharan Africa. In some countries with high HIV prevalence rates, life expectancy has declined by more than a decade and in a few cases by more than two decades. Even in countries with HIV prevalence of around 5 percent (close to the average for sub-Saharan Africa), the epidemic can reverse gains in life expectancy and other health outcomes achieved over one or two decades.This volume highlights work conducted under the umbrella of a World Bank work program on "The Fiscal Dimension of HIV/AIDS, 410 0$aWorld Bank e-Library. 606 $aAIDS (Disease)$xEconomic aspects$zAfrica, Southern 606 $aAIDS (Disease)$xEconomic aspects$zUganda 606 $aHIV infections$xEconomic aspects$zAfrica, Southern 606 $aHIV infections$xEconomic aspects$zUganda 606 $aHIV infections$xGovernment policy$zAfrica, Southern$xFinance 606 $aHIV infections$xGovernment policy$zUganda$xFinance 615 0$aAIDS (Disease)$xEconomic aspects 615 0$aAIDS (Disease)$xEconomic aspects 615 0$aHIV infections$xEconomic aspects 615 0$aHIV infections$xEconomic aspects 615 0$aHIV infections$xGovernment policy$xFinance. 615 0$aHIV infections$xGovernment policy$xFinance. 676 $a362.196/979200968 700 $aLule$b Elizabeth$01465778 701 $aHaacker$b Markus$01465779 801 0$bIEN/DLC 801 1$bIEN 906 $aBOOK 912 $a9910789486703321 996 $aThe fiscal dimensions of HIV$93675987 997 $aUNINA